AI for Renal Tumors Using Non-Contrast CT
An Artificial Intelligence Model for Screening and Diagnosis of Renal Tumors Based on Non-Contrast CT
1 other identifier
observational
10,000
1 country
1
Brief Summary
The goal of this observational study is to learn whether the artificial intelligence method can automatically identify and diagnose renal lesions using non-contrast CT or opportunistic screening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2025
CompletedFirst Posted
Study publicly available on registry
December 26, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
December 26, 2025
October 1, 2025
2.9 years
December 13, 2025
December 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Building an intelligent diagnostic system for renal diseases based on CT scans.
To construct an intelligent system for the detection of renal mass lesions and their differentiation into cysts, benign, and malignant neoplasms.
1 year
Secondary Outcomes (1)
Further develop artificial intelligence model to effectively diagnose pathological types of common renal tumors.
1 year
Eligibility Criteria
Patients who underwent an abdominal CT examination.
You may qualify if:
- Patients who underwent an abdominal CT examination.
- Patients with renal lesions were managed according to standard clinical pathways, which included follow-up, biopsy, or surgery.
- Malignant lesions were pathologically confirmed; benign lesions were confirmed by either pathological diagnosis or imaging follow-up.
- No prior treatment had been received for the renal disease.
You may not qualify if:
- Patients refuse to undergo recommended follow-up, biopsy, or surgery, which precluded definitive diagnosis of the renal lesion.
- Absence of complete pathological confirmation for lesions suspected to be malignant.
- Patients have received any form of prior treatment for the renal lesion.
- Poor image quality that hampered diagnostic evaluation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
Study Sites (1)
Fudan university Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Head of Radiology, Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
December 13, 2025
First Posted
December 26, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
December 26, 2025
Record last verified: 2025-10